BRIEF-Igm Biosciences Inc Says On May 5, Co Received Notice Of Termination Genzyme Corp That Certain Collaboration And License Agreement

Reuters

05/09

IGM Biosciences Inc IGMS.O:

IGM BIOSCIENCES INC SAYS ON MAY 5, CO RECEIVED NOTICE OF TERMINATION GENZYME CORP THAT CERTAIN COLLABORATION AND LICENSE AGREEMENT
IGM BIOSCIENCES - IN CONNECTION WITH AGREEMENT TERMINATION, CO IMPLEMENTED ABOUT 80% REDUCTION IN REMAINING WORKFORCE
IGM BIOSCIENCES INC SAYS CLOSED MOST OF REMAINING LAB AND OFFICE FACILITIES TO PRESERVE CASH
IGM BIOSCIENCES INC SAYS CONTINUES TO EVALUATE POTENTIAL STRATEGIC ALTERNATIVES AND REORGANIZATION OPTIONS

Source text: [ID:n0001193125-25-116071]

Further company coverage: IGMS.O

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2534446193"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2534446193\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2534446193?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-05-09 06:24","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2534446193","market":"nz","top_or_hot":-1,"title":"BRIEF-Igm Biosciences Inc Says On May 5, Co Received Notice Of Termination  Genzyme Corp That Certain Collaboration And License Agreement","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Igm Biosciences Inc Says On May 5, Co Received Notice Of Termination  Genzyme Corp That Certain Collaboration And License Agreement</title></head><body><p><a href=\"https://laohu8.com/S/IGMS\">IGM Biosciences</a> Inc <span>IGMS.O</span>:</p><ul><li><p>IGM BIOSCIENCES INC SAYS ON MAY 5, CO RECEIVED NOTICE OF TERMINATION  GENZYME CORP THAT CERTAIN COLLABORATION AND LICENSE AGREEMENT</p></li><li><p>IGM BIOSCIENCES - IN CONNECTION WITH AGREEMENT TERMINATION, CO IMPLEMENTED ABOUT 80% REDUCTION IN REMAINING WORKFORCE</p></li><li><p>IGM BIOSCIENCES INC SAYS CLOSED MOST OF REMAINING LAB AND OFFICE FACILITIES TO PRESERVE CASH</p></li><li><p>IGM BIOSCIENCES INC SAYS CONTINUES TO EVALUATE POTENTIAL STRATEGIC ALTERNATIVES AND REORGANIZATION OPTIONS</p></li></ul><p>Source text: [ID:n0001193125-25-116071]</p><p>Further company coverage: <span>IGMS.O</span></p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Igm Biosciences Inc Says On May 5, Co Received Notice Of Termination  Genzyme Corp That Certain Collaboration And License Agreement</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Igm Biosciences Inc Says On May 5, Co Received Notice Of Termination  Genzyme Corp That Certain Collaboration And License Agreement\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-05-09 06:24</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Igm Biosciences Inc Says On May 5, Co Received Notice Of Termination  Genzyme Corp That Certain Collaboration And License Agreement</title></head><body><p><a href=\"https://laohu8.com/S/IGMS\">IGM Biosciences</a> Inc <span>IGMS.O</span>:</p><ul><li><p>IGM BIOSCIENCES INC SAYS ON MAY 5, CO RECEIVED NOTICE OF TERMINATION  GENZYME CORP THAT CERTAIN COLLABORATION AND LICENSE AGREEMENT</p></li><li><p>IGM BIOSCIENCES - IN CONNECTION WITH AGREEMENT TERMINATION, CO IMPLEMENTED ABOUT 80% REDUCTION IN REMAINING WORKFORCE</p></li><li><p>IGM BIOSCIENCES INC SAYS CLOSED MOST OF REMAINING LAB AND OFFICE FACILITIES TO PRESERVE CASH</p></li><li><p>IGM BIOSCIENCES INC SAYS CONTINUES TO EVALUATE POTENTIAL STRATEGIC ALTERNATIVES AND REORGANIZATION OPTIONS</p></li></ul><p>Source text: [ID:n0001193125-25-116071]</p><p>Further company coverage: <span>IGMS.O</span></p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4505","symbol_name":"高瓴资本持仓","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250508:nFWN3RG4U5:1","article_id":"2534446193","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2534446193","pubTimestamp":1746743087,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Igm Biosciences Inc Says On May 5, Co Received Notice Of Termination  Genzyme Corp That Certain Collaboration And License AgreementIGM Biosciences Inc IGMS.O:IGM BIOSCIENCES INC SAYS ON MAY 5, CO RECEIVED NOTICE OF TERMINATION  GENZYME CORP THAT CERTAIN COLLABORATION AND LICENSE AGREEMENTIGM BIOSCIENCES - IN CONNECTION WITH AGREEMENT TERMINATION, CO IMPLEMENTED ABOUT 80% REDUCTION IN REMAINING WORKFORCEIGM BIOSCIENCES INC SAYS CLOSED MOST OF REMAINING LAB AND OFFICE FACILITIES TO PRESERVE CASHIGM BIOSCIENCES INC SAYS CONTINUES TO EVALUATE POTENTIAL STRATEGIC ALTERNATIVES AND REORGANIZATION OPTIONSSource text: [ID:n0001193125-25-116071]Further company coverage: IGMS.O","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4505":"高瓴资本持仓","BK4139":"生物科技","IGMS":"IGM Biosciences"},"translate_title":"简介-Igm Biosciences Inc表示，5月5日，Co收到Genzyme Corp终止某些合作和许可协议的通知","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"IGMS":0.9},"content_text":"BRIEF-Igm Biosciences Inc Says On May 5, Co Received Notice Of Termination  Genzyme Corp That Certain Collaboration And License AgreementIGM Biosciences Inc IGMS.O:IGM BIOSCIENCES INC SAYS ON MAY 5, CO RECEIVED NOTICE OF TERMINATION  GENZYME CORP THAT CERTAIN COLLABORATION AND LICENSE AGREEMENTIGM BIOSCIENCES - IN CONNECTION WITH AGREEMENT TERMINATION, CO IMPLEMENTED ABOUT 80% REDUCTION IN REMAINING WORKFORCEIGM BIOSCIENCES INC SAYS CLOSED MOST OF REMAINING LAB AND OFFICE FACILITIES TO PRESERVE CASHIGM BIOSCIENCES INC SAYS CONTINUES TO EVALUATE POTENTIAL STRATEGIC ALTERNATIVES AND REORGANIZATION OPTIONSSource text: [ID:n0001193125-25-116071]Further company coverage: IGMS.O","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"corporation,event","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}